UK Life Sciences Market Entry
Virtual 1-2-1 Connector Workshop
Meet Healthtech & Healthcare Experts from London, Manchester, Leeds, Edinburgh, Cambridge and Oxford
4th & 5th July 2023 / 9:00 -12:00 BST
4th & 5th July 2023
9:00 - 12:00 BST
£99 per company
Payment details provided upon acceptance
Market Entry briefings
Followed by 1-2-1 advisory sessions
Exclusive Access to the UK Healthtech and Healthcare Markets
With an annual market of over £80 billion, the UK is the perfect launch pad for ambitious French medtech devices, digital health, pharma, biopharma, CRO and academic companies to expand internationally. Success in the UK is then often a platform to scale up in the US too!
GTM Global is hosting a suite of Virtual Market Entry Lifesciences Workshops for Healthtech and Healthcare companies from France - to land and expand in the UK.
On registration, a member of the GTM team will speak with you directly and qualify your UK market entry plans. We'll identify with you a roadmap for UK expansion. We'll then directly connect you to a suite of 1-2-1 virtual sessions with UK experts in the NHS, academia, business development, funding and compliance.
Imagine the huge value of having these qualified virtual sessions on UK market entry, without the costs of flights, time and accommodation!
Why Should You Attend
Connect with specialist in-country advisers from London, Manchester, Leeds, Edinburgh, Cambridge, and Oxford, and get advice on all aspects of UK market entry and expansion.
Mark StimpfigCo Founder GTM Global
Providing advice & guidance for tech and digital scale up brands to expand internationally & support companies looking to land & expand into the Greater Phoenix region USA
Chris HowieDirector of Life Sciences, GTM Global
Chris has over 30 years of experience in key sectors such as MedTech devices, Pharma, Bio Pharma, CRO and Academia. He has great access to mission-critical clinical trial and evaluator channels as well as funding, investment, government, and regulatory bodies and networks.
Mark TreherneCommercial Research Scientist
30 years of experience in the discovery & diagnosis of novel treatments for diseases with unmet medical needs. Formerly at Pfizer, doing research into neurodegenerative diseases in the UK. Subsequently, set up Cambridge Drug Discovery in 1997 and sold it in 2001. Since then, helped to raise £300mln for life sciences companies, and enabled inward investment into the UK of £6bln.
Keith MillerLife-Science Strategy Consultant
Life Science Specialist with a track record of delivery in both industry and private sector roles. Consultancies and interims have included, Department for International Trade, Northern Health Science Alliance, MedCity, US Pharma and Molecular Pathology Laboratory Network Inc and West Midlands Growth Company.
Julie Lebouleux-LinosiSenior Trade and Investment Adviser, Health and Life Sciences, British Embassy Paris
Julie matching French and British businesses and assisting their international expansion objectives.
Tony YoungNational Clinical Lead for Innovation, NHS England
Tony provides national-level leadership for innovation for the NHS in England. He advises government ministers, civil servants across government, NHS England, other arm’s length bodies, charities, UK and global industry, foreign governments and organisations on innovation in healthcare.
Christina PecoraroAccount Manager, QRx Partners
Bringing over a decade of experience, Christina has been employed in quality assurance, medical device regulatory affairs, and business development. She gets involved in supporting all sizes of medical device companies such as Boston Scientific and Medtronic, to small startups.
Mark SwansonHealthcare Regulatory Advisor, QRx Partners
Mark has been a leader in Quality and Regulatory for over 25 years. His career includes roles in quality engineering, design assurance, audit, and quality management for companies, including St. Jude Medical and Medtronic, and has provided guidance to numerous medical device and pharmaceutical manufacturers of all sizes.
Stephen MarshmanBusiness Development Director, SGK
Stephen assists organizations of all sizes in implementing effective processes for developing packaging and branded content. His expertise in highly regulated industries, particularly the pharmaceutical sector, has earned him a reputation for helping clients optimize their marketing supply chains with a proven track record of success.
Martin ShiderovAssociate Director, Akeso & Company
Martin is an Associate Director at Akeso & Company, an independent and dynamic management consultancy specialising in delivering operational improvements across the Healthcare and Life Science industry. They help companies achieve their goals through expert consulting, analytics and managed service support.
Malcolm JoyLead Partner, Frazier & Deeter UK LLP
Malcolm is the Lead Partner of Frazier & Deeter UK, a firm providing advisory services to mid-market businesses, with expertise in supporting cross-border businesses. In addition to leading the firm’s growth in the UK, Malcolm is responsible for tax advisory services and transaction advisory services. Malcolm is also the Global Leader of Transfer Pricing Services at Frazier & Deeter.
Thomas WellsSenior Manager - R&D, Frazier & Deeter UK LLP
Thomas is a Senior Manager - R&D at Frazier & Deeter UK, a firm providing advisory services to mid-market businesses, with expertise in supporting cross-border businesses.